GREG D. CARMICHAEL - 16 Jan 2024 Form 4 Insider Report for Encompass Health Corp (EHC)

Role: Director
Signature: /s/ Patrick Darby, attorney-in-fact for Greg D. Carmichael
Issuer symbol: EHC
Transactions as of: 16 Jan 2024
Net transactions value: +$1,127
Form type: 4
Filing time: 17 Oct 2024, 13:03:20 UTC
Previous filing: 17 Oct 2023
Next filing: 16 Apr 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	EHC	Encompass Health Common Stock	Small acquisition under Rule 16a-6	$275	+4	+0.03%	$68.64	13,055	16 Jan 2024	Direct	F1
transaction	EHC	Encompass Health Common Stock	Small acquisition under Rule 16a-6	$244	+3	+0.02%	$81.47	13,079	15 Apr 2024	Direct	F1
transaction	EHC	Encompass Health Common Stock	Small acquisition under Rule 16a-6	$608	+7	+0.04%	$86.89	17,088	15 Jul 2024	Direct	F1
transaction	EHC	Encompass Health Common Stock	Award	$0	+24	+0.14%	$0.000000	17,112	15 Oct 2024	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This acquisition is a dividend reinvestment administered by the reporting person's broker. It is eligible for deferred reporting on Form 5 pursuant to Rule 16a-6 but is being reported earlier than required on Form 4.
F2	Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On October 15, 2024, Encompass Health paid a dividend on its common stock of $0.17 per share and the closing price was $96.33. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment.

Content

This acquisition is a dividend reinvestment administered by the reporting person's broker. It is eligible for deferred reporting on Form 5 pursuant to Rule 16a-6 but is being reported earlier than required on Form 4.

Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On October 15, 2024, Encompass Health paid a dividend on its common stock of $0.17 per share and the closing price was $96.33. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment.